ScholarIQanswers from OpenAlex
Azienda USL di Bologna
InstitutionResearch output, impact & collaborations
Azienda USL di Bologna is a institution indexed in ScholarIQ from OpenAlex.
What is known about Azienda USL di Bologna?
ScholarIQrecord summary
Azienda USL di Bologna is a research organisation in Bologna, IT. OpenAlex records 10,655 works and 423,894 citations for it. 3,817 researchers list it as their most recent affiliation.
How many works does Azienda USL di Bologna have?
ScholarIQindexed works
Azienda USL di Bologna has 10,655 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Azienda USL di Bologna have?
ScholarIQcitation count
Azienda USL di Bologna has 423,894 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Azienda USL di Bologna?
ScholarIQresearcher count
Azienda USL di Bologna has 3,817 researchers in the ScholarIQ index.
What is the average h-index at Azienda USL di Bologna?
ScholarIQavg h-index
Azienda USL di Bologna has an average h-index of 72.9 in OpenAlex.
What is the ROR of Azienda USL di Bologna?
ScholarIQror
The ROR for Azienda USL di Bologna is on the source record.
What is the OpenAlex record for Azienda USL di Bologna?
ScholarIQopenalex
The OpenAlex for Azienda USL di Bologna is on the source record.
Who are the most-cited researchers behind Azienda USL di Bologna?
ScholarIQtop researchers by citations
What are the most-cited papers on Azienda USL di Bologna?
ScholarIQmost cited works
Bosentan Therapy for Pulmonary Arterial Hypertension
Lewis J. Rubin, David B. Badesch, Robyn J. Barst, Nazzareno Galiè, Carol M. Black, Anne Keogh, Tomás Pulido, Adaani Frost, Sébastiên Roux, Isabelle Leconte, Michael J. Landzberg, Gérald Simonneau
Functional Gastroduodenal Disorders
Jan Tack, Nicholas J. Talley, Michael Camilleri, Gerald Holtmann, P. Hu, Juan-R. Malagelada, Vincenzo Stanghellini
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun‐Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean‐Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo Abada, Masatoshi Kudo
Gastroduodenal Disorders
Vincenzo Stanghellini, Francis K.L. Chan, William L. Hasler, Juan R. Malagelada, Hidekazu Suzuki, Jan Tack, Nicholas J. Talley
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
Giovanni Barbara, Vincenzo Stanghellini, Roberto De Giorgio, Cesare Cremon, Graeme S. Cottrell, Donatella Santini, Gianandrea Pasquinelli, Antonio Maria Morselli‐Labate, Eileen F. Grady, Nigel W. Bunnett, Stephen M. Collins, Roberto Corinaldesi
How much of the research on Azienda USL di Bologna is open access?
ScholarIQopen access share
58%OPEN ACCESS